XML 77 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity Under Equity-Based Plans
The following table summarizes stock option activity for the year ended December 31, 2023:
Number
of Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
(in millions)
Balance at December 31, 2022190,275 $20.50 1.5$
Exercised(182,067)20.50 14 
Balance at December 31, 2023 (1)
8,208 $19.50 0.45$1 
(1)    All options are vested and exercisable.
Schedule of Additional Disclosure for Stock Options
Year Ended December 31,
Additional Disclosures for Stock Options (in millions)202320222021
Total intrinsic value of options exercised 14 
Cash received from options exercised 4 
Schedule of RSU and RSA Activity Under Equity-Based Plans
The following tables summarize RSU activity for the year ended December 31, 2023:
Time-based RSUs
Total Number
of RSUs
Weighted-Average
Grant Date
Fair Value
Nonvested at December 31, 20221,198,561 $80.75 
Granted769,286 78.27 
Vested(617,937)76.25 
Forfeited(120,708)82.58 
Nonvested at December 31, 20231,229,202 $80.88 
Year Ended December 31,
Additional Disclosures for equity-based plans 202320222021
Total grant date fair value of shares granted (in millions)$60 $85 $47 
Total grant date fair value of shares vested (in millions)$47 $42 $34 
Shares withheld to settle payroll tax liabilities related to vesting of shares held by employees213,569 204,191 207,603 
Performance-based RSUs
Total Number Shares
Weighted-Average
Grant Date
Fair Value
Nonvested at December 31, 2022202,586 $86.82 
Granted177,067 79.05 
Vested(156,642)86.22 
Nonvested at December 31, 2023223,011 $81.08 
Schedule of Additional Disclosures for Equity-Based Plans
Year Ended December 31,
Additional Disclosures for equity-based plans 202320222021
Total grant date fair value of shares granted (in millions) (1)
$14 $20 $16 
Total grant date fair value of shares vested (in millions)$14 $17 $
Shares withheld to settle payroll tax liabilities related to vesting of shares held by employees74,923 119,901 77,787 
(1)    Amount includes fair value of finalized additional grant related to the most recently ended performance period.
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options
In applying the Black Scholes option valuation model for the ESPP options, we use the following assumptions:
Year Ended December 31,
(in millions)202320222021
Expected Term (in Years)0.50.50.5
Expected Volatility
29-35%
21-39%
21-35%
Risk-Free Interest Rate
5.3-5.4%
0.7-4.5%
0.4-0.7%
Expected Dividend Yield0 %%%
Shares Issued under ESPP175,446 158,134 136,861 
Schedule of Stock-based Compensation Expense Stock based compensation expense and other disclosures for stock based awards made to our employees pursuant to the equity plans were as follows: 
 Year Ended December 31,
(in millions)202320222021
Cost of providing services$14 $13 $12 
Sales and marketing8 
General and administrative33 38 29 
Systems development and programming costs4 
Total stock based compensation expense$59 $62 $50 
Total stock based compensation capitalized$3 $$
Income tax benefit related to stock based compensation expense$13 $13 $10 
Tax benefit realized$19 $14 $16 
The table below summarizes unrecognized compensation expense for the year ended December 31, 2023 associated with the following:
Amount
(in millions)
Weighted-Average Period (in Years)
Nonvested time based RSUs$92 2.47
Nonvested performance based RSUs10 1.66